4DMedical Ltd
ASX:4DX
Balance Sheet
Balance Sheet Decomposition
4DMedical Ltd
4DMedical Ltd
Balance Sheet
4DMedical Ltd
| Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
1
|
2
|
3
|
8
|
81
|
51
|
70
|
31
|
7
|
|
| Cash |
1
|
2
|
3
|
8
|
81
|
51
|
70
|
31
|
7
|
|
| Total Receivables |
1
|
1
|
2
|
2
|
4
|
6
|
7
|
6
|
7
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Other Receivables |
1
|
1
|
1
|
1
|
4
|
4
|
6
|
5
|
6
|
|
| Inventory |
1
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
|
| Total Current Assets |
3
|
3
|
5
|
11
|
86
|
59
|
79
|
39
|
17
|
|
| PP&E Net |
0
|
0
|
1
|
2
|
3
|
10
|
9
|
9
|
7
|
|
| PP&E Gross |
0
|
0
|
1
|
2
|
3
|
10
|
9
|
9
|
7
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
4
|
|
| Intangible Assets |
1
|
2
|
3
|
3
|
4
|
5
|
5
|
29
|
28
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
43
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
43
|
|
| Total Assets |
5
N/A
|
5
+10%
|
9
+66%
|
16
+75%
|
93
+485%
|
74
-20%
|
93
+25%
|
120
+29%
|
95
-21%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
2
|
0
|
2
|
3
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Short-Term Debt |
0
|
1
|
0
|
17
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
2
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
0
|
1
|
8
|
7
|
6
|
12
|
17
|
14
|
|
| Total Current Liabilities |
2
|
2
|
3
|
27
|
8
|
10
|
17
|
22
|
19
|
|
| Long-Term Debt |
0
|
0
|
2
|
1
|
1
|
5
|
4
|
4
|
3
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
1
|
|
| Total Liabilities |
2
N/A
|
2
-1%
|
4
+167%
|
28
+518%
|
9
-66%
|
15
+60%
|
21
+45%
|
49
+129%
|
31
-38%
|
|
| Equity | ||||||||||
| Common Stock |
8
|
11
|
18
|
19
|
142
|
142
|
184
|
218
|
240
|
|
| Retained Earnings |
4
|
8
|
13
|
32
|
58
|
82
|
113
|
147
|
175
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
4
+16%
|
5
+21%
|
12
N/A
|
83
N/A
|
60
-29%
|
71
+20%
|
71
-1%
|
64
-9%
|
|
| Total Liabilities & Equity |
5
N/A
|
5
+10%
|
9
+66%
|
16
+75%
|
93
+485%
|
74
-20%
|
93
+25%
|
120
+29%
|
95
-21%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
265
|
265
|
265
|
265
|
294
|
295
|
345
|
410
|
466
|
|